These included key genes associated with cytotoxic anti-tumor T cell responses (GZMA, GZMB, PRF1), co-stimulation of T cells (CD27, CD28, ICOS), and genes associated with other immune processes, including Type I IFN response (TNF, TNFSF10), as well as T cell exhaustion (CTLA4). The gene discussed is CTLA4; the disease is neoplasm.